This activity is intended for BCACPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS).
This 2-hour webinar is an interactive discussion between a pain and palliative care expert and behavioral health expert. Drs. Gable and Herndon begin the session with a review of the commonality of pain conditions, trauma and post-traumatic stress disorder, and substance use disorders. They discuss the pros and cons to the prescribing of both opioids and benzodiazepines for the treatment of pain and mental health disorders, and elaborate on cases where the medications are considered safe to continue or risk would warrant a thoughtful taper plan. They interweave their clinical experiences working in collaborative care models within Federally Qualified Health Centers and discuss best practice pharmacy interventions that involve both pain and behavioral health. Listeners will walk through a patient case that highlights how to effectively treat chronic pain and opioid use disorder collaboratively. These activities are part of the APhA professional development program for BCACP recertification approved by BPS.
Continuing Pharmacy Education Credit
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-297-H04-P.
To obtain credit for The Intersection of Pain, Mental Health, and Substance Use: Best Practices in Collaborative Care, watch the recording, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: December 15, 2019
Expiration date: December 15, 2022
Learning Level: 2
Activity Type: Application-based
After completing the live course you will be provided Instructions for obtaining CPE credit
Target Audience: Board-certified ambulatory care pharmacists
Kelly N. Gable, Pharm.D, BCPP
Professor and Coordinator of Global Partnerships
SIUE School of Pharmacy
Chris Herndon, PharmD, BCACP
School of Pharmacy
Southern Illinois University Edwardsville
1. Elaborate on the prevalence and clinical presentation of pain conditions, trauma, and substance use disorders.
2. Review how to incorporate trauma-informed care into the assessment of pain and substance use.
3. Identify safety concerns and appropriate clinical use of opioid and benzodiazepine treatments.
4. Discuss clinical examples that involve the successful discontinuation of opioid and benzodiazepine medications.
5. Describe collaborative care models that incorporate the treatment of both pain and behavioral health conditions.
6. Design a treatment plan based on patient-specific characteristics that highlights the management of pain and substance use disorders.
The Intersection of Pain, Mental Health, and Substance Use: Best Practices in Collaborative Care is an online continuing education activity for pharmacists developed by the American Pharmacists Association.
APhA's editorial staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at pharmacist.com/education.
There is a $40 member fee and a $70 nonmember fee to participate in this activity which includes the recertification exam. No refunds.
NEED HELP? Contact Education@aphanet.org and include “Ambulatory Care” in the email subject line.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-19-297-H04-P||0.2 CEUs||December 15, 2019 - December 15, 2022|
|0202-0000-19-297-H04-P||2 Hours||December 15, 2019 - December 15, 2022|